GlassScriptPhysician profile
Joseph J Bear
NPI 1538304217
$14,410.21
in general payments reported to CMS, 2019-2025
55 companies · $3,305 in 2025
The $3,305 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $756 · 2021: $2,198 · 2022: $1,756 · 2023: $3,051 · 2024: $2,173 · 2025: $3,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,660 · Honoraria: $350 · Travel and Lodging: $345 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,660.26 |
| Honoraria | $350.00 |
| Travel and Lodging | $345.06 |
| Education | $173.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,526.23 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $1,698.57 | 2019-2025 | Rezum Generator, Lithovue, Ams 700 |
| Procept Biorobotics Corporation | $1,378.62 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $916.05 | 2019-2025 | Porges Coloplast, Speedicath, Isiris Astent Removal Device |
| Astellas Pharma US INC | $746.43 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $645.44 | 2021-2025 | Prolaris, Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $644.57 | 2020-2025 | |
| Abbvie INC. | $542.94 | 2019-2025 | Botox, Lupron Depot |
| Dendreon Pharmaceuticals LLC | $503.44 | 2022-2025 | Provenge |
| Myovant Sciences INC. | $335.75 | 2021-2022 | |
| Axonics, INC. | $295.81 | 2021-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $284.91 | 2019-2023 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $277.52 | 2022-2025 | |
| Ambu INC. | $274.64 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $265.17 | 2023-2025 | Orgovyx |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.